Table 2 Comparing demographic and laboratory data between COV and COV-HD patients

Age

60.6 (13.6)

54 (8.9)

0.115 ^a

 Male

9 (30)

21 (70)

0.006

 Female

21 (70)

9 (30)

Diabetes

14 (46.7)

13 (43)

0.5

Number of days of hospital admission

15 (3–33)

3 (0–12)

0.001 ^a

O2 Saturation at admission

88 (60–99)

89 (72–96)

0.008 ^a

 OPC

2 (6.7)

12 (40)

0.009^c

 Ward

14 (46.7)

10 (33.5)

 ICU

14 (46.7)

8 (26.5)

 OPC

1 (3.3)

11 (36.5)

0.005^c

 Discharge

16 (53.3)

12 (40)

 Death

13 (43.3)

7 (23.5%)

 GGO percentage%

50 (0–86)

45 (0–69)

0.19 ^a

 Total severity score in CT (TSS) (out of 20)

7.5 (2–15)

7 (2–15)

0.12 ^a

 TSS (Severe > 7.5)

16 (53%)

10 (33%)

0.08 ^a

 Hemoglobin (mg/dl)

11.25 (6.5–17.6)

9.5 (7.8–12.7)

< 0.001 ^a

 Total WBCs (cell/ μl)

8616 (3200–20,800)

7300 (3560–22,500)

0.423^a

 Neutrophil (cell/ μl)

6790 (2080–14,890)

4346 (2242–18,225)

0.152 ^a

 Lymphocyte (cell/ μl)

1100 (500–3600)

1204 (480–5000)

0.9 ^a

 NL ratio

5.6 (1.81–13.22)

2.8 (1.84–21.75)

0.132 ^a

 Less than 200

19 (63.3%)

13 (43.3)

0.04 ^a

 200–500

8 (26.7%)

4 (13.3)

 More than 500

3 (10%)

13 (43.3)

 CD4+ T cells (cell/ μl)

33.8 (2.2–359.1)

52.16 (1.92–399.6)

0.4 ^a

 Tregs (cell/ μl)

0.011 (0–0.33)

0.028 (0–5.77)

0.1 ^a

 CD39 expressing Tregs (cell/ μl)

0.002 (0–0.14)

0.006 (0–5.6)

0.04 ^a